Buscar
01/03/2022
Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing
Sanchez, E, Sapina-Beltran, E, Gavalda, R, Barbe, F, Torres, G, Sauret, A, Dalmases, M, Lopez-Cano, C, Gutierrez-Carrasquilla, L, Bermudez-Lopez, M, Fernandez, E, Purroy, F, Castro-Boque, E, Farras-Salles, C, Pamplona, R, Mauricio, D, Hernandez, C, Simo, R, Lecube, A. Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing. Journal of Clinical Medicine. 2022; 11(5)DOI:10.3390/jcm11051413. PMID:35268504. IF:3.900(Q2/4D).
09/02/2022
Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population
Cebrian-Cuenca, AM, Mata-Cases, M, Franch-Nadal, J, Mauricio, D, Orozco-Beltran, D, Consuegra-Sanchez, L. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population. European Journal of Preventive Cardiology. 2022; 28(18)DOI:10.1093/eurjpc/zwaa073. PMID:33733654. IF:8.300(Q1/2D).
09/02/2022
Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial
van Poppel, MNM, Corcoy, R, Hill, D, Simmons, D, Mendizabal, L, Zulueta, M, Simon, L, Desoye, G, Perez, JMA, Kautzky-Willer, A, Harreiter, J, Damm, P, Mathiesen, E, Jensen, DM, Andersen, LLT, Dunne, F, Lapolla, A, Dalfra, MG, Bertolotto, A, van Poppel, M, Jelsma, JGM, Snoek, FJ, Galjaard, S, Wender-Ozegowska, E, Zawiejska, A, Devlieger, R, DALI Core Investigator Grp. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial. AMERICAN JOURNAL OF CLINICAL NUTRITION. 2022; 115(2)DOI:10.1093/ajcn/nqab347. PMID:34669935. IF:7.100(Q1/2D).
01/02/2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
Magliano, DJ, Chen, L, Carstensen, B, Gregg, EW, Pavkov, ME, Salim, A, Andes, LJ, Balicer, R, Baviera, M, Chan, JCN, Cheng, YLJ, Gardiner, H, Gulseth, HL, Gurevicius, R, Ha, KH, Jermendy, G, Kim, DJ, Kiss, Z, Leventer-Roberts, M, Lin, CY, Luk, AOY, Ma, S, Mata-Cases, M, Mauricio, D, Nichols, GA, Pildava, S, Porath, A, Read, SH, Robitaille, C, Roncaglioni, MC, Ruiz, PLD, Wang, KL, Wild, SH, Yekutiel, N, Shaw, JE. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes & Endocrinology. 2022; 10(2)DOI:10.1016/S2213-8587(21)00327-2. PMID:35026157. IF:44.500(Q1/1D).
01/02/2022
Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database
Franch-Nadal, J, Real, J, Mata-Cases, M, Ortega, E, Valles, JA, Vlacho, B, Mauricio, D. Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database. Endocrinologia Diabetes y Nutricion. 2022; 69(2)DOI:10.1016/j.endinu.2021.01.013. PMID:34088634. IF:1.900(Q4/9D).
31/01/2022
NAD plus -Increasing Strategies to Improve Cardiometabolic Health?
Blanco-Vaca, F, Rotllan, N, Canyelles, M, Mauricio, D, Escola-Gil, JC, Julve, J. NAD plus -Increasing Strategies to Improve Cardiometabolic Health?. Frontiers in Endocrinology. 2022; 12DOI:10.3389/fendo.2021.815565. PMID:35173682. IF:5.200(Q1/3D).
01/01/2022
Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados
Teis A., Castelblanco E., Cediel G., Amigó N., Julve J., Ribalta J., Guardiola M., Franch J., Bermúdez-López M., Codina P., Lupón J., Mauricio D., Alonso N., Bayés-Genís A.. Perfil lipoproteico por espectroscopia nuclear magnética en pacientes con insuficiencia cardiaca crónica comparado con controles emparejados. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(11)DOI:10.1016/j.recesp.2021.09.007. PMID:. IF:(Q/D).
01/01/2022
Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality
Ramon, J, Llaurado, G, Guerri, R, Climent, E, Ballesta, S, Benaiges, D, Lopez-Montesinos, I, Navarro, H, Fernandez, N, Carrera, MJ, Mauricio, D, Flores-Le Roux, JA, Chillaron, JJ. Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality. DIABETES CARE. 2022; 45(1)DOI:10.2337/dc21-1321. PMID:34782352. IF:16.200(Q1/1D).